ATE489478T1 - Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation - Google Patents
Nukleinsäuren, polypeptide und verfahren zur apoptosemodulationInfo
- Publication number
- ATE489478T1 ATE489478T1 AT02759167T AT02759167T ATE489478T1 AT E489478 T1 ATE489478 T1 AT E489478T1 AT 02759167 T AT02759167 T AT 02759167T AT 02759167 T AT02759167 T AT 02759167T AT E489478 T1 ATE489478 T1 AT E489478T1
- Authority
- AT
- Austria
- Prior art keywords
- apoptosis
- polypeptides
- nucleic acids
- dhs
- eif
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/909,796 US6867237B1 (en) | 2001-07-23 | 2001-07-23 | DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans |
US10/141,647 US7166467B2 (en) | 2001-07-23 | 2002-05-07 | Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
PCT/US2002/023254 WO2003010286A2 (en) | 2001-07-23 | 2002-07-23 | Nucleic acids, polypeptides, and methods for modulating apoptosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE489478T1 true ATE489478T1 (de) | 2010-12-15 |
Family
ID=26839315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02759167T ATE489478T1 (de) | 2001-07-23 | 2002-07-23 | Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation |
Country Status (12)
Country | Link |
---|---|
US (3) | US7166467B2 (de) |
EP (1) | EP1546375B1 (de) |
JP (2) | JP2005519583A (de) |
KR (1) | KR100944938B1 (de) |
CN (1) | CN100352923C (de) |
AT (1) | ATE489478T1 (de) |
AU (1) | AU2002324519B2 (de) |
CA (2) | CA2857312A1 (de) |
DE (1) | DE60238449D1 (de) |
IL (1) | IL159966A0 (de) |
NZ (1) | NZ531225A (de) |
WO (1) | WO2003010286A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217517B2 (en) * | 2001-07-23 | 2007-05-15 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, and methods for modulating apoptosis |
US7381708B2 (en) | 2001-07-23 | 2008-06-03 | Sensco Technologies, Inc. | Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye |
US7166467B2 (en) * | 2001-07-23 | 2007-01-23 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
US7968523B2 (en) | 2001-07-23 | 2011-06-28 | Senesco Technologies, Inc. | Method for inducing apoptosis using apoptosis-specific EIF5-A |
CN101014708B (zh) * | 2003-03-05 | 2011-11-02 | 森尼斯科技术公司 | 反义寡核苷酸或siRNA在抑制eIF-5A1表达中的应用 |
KR20050098954A (ko) * | 2003-03-05 | 2005-10-12 | 세네스코 테크놀로지스 인코포레이티드 | 이아이에프-5에이1의 발현을 억제하기 위한 안티센스올리고뉴클레오타이드 또는 에스아이알엔에이의 이용 |
NZ544159A (en) * | 2003-06-06 | 2009-04-30 | Senesco Technologies Inc | Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics |
US20140371299A1 (en) * | 2004-06-07 | 2014-12-18 | Senesco Technologies, Inc. | Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis |
EP1769075A2 (de) * | 2004-07-20 | 2007-04-04 | Senesco Technologies, Inc. | Verwendung von apoptosis spezifischen eif-5a sirnas und antisense polynukleotiden zur verhinderung/unterdrückung von entzündlichen prozessen |
TW200634154A (en) * | 2004-12-03 | 2006-10-01 | Senesco Technologies Inc | Apoptosis-specific EIF-5A and polynucleotides encoding same |
WO2007070824A2 (en) * | 2005-12-13 | 2007-06-21 | Senesco Technologies, Inc. | Use of eif-5a to kill multiple myeloma cells |
WO2007109677A2 (en) * | 2006-03-20 | 2007-09-27 | Senesco Technologies, Inc. | A novel method of protecting islet cells from apoptosis during the donor harvesting process |
US8703929B2 (en) | 2008-03-07 | 2014-04-22 | Senesco Technologies, Inc. | Compositions comprising siRNA and plasmids |
US8492521B2 (en) | 2008-05-27 | 2013-07-23 | Yoshinori Seko | Oxidative stress responsive apoptosis inducing protein eIF5A |
US8445638B2 (en) | 2008-09-03 | 2013-05-21 | Senesco Technologies, Inc. | Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells |
CN114231551B (zh) * | 2021-12-24 | 2023-09-29 | 云南大学 | 蛋白在促进昆虫淋巴细胞凋亡和/或防治害虫中的应用 |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2941668A1 (de) * | 1979-10-15 | 1981-04-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Kardiotachometer |
CA1199371A (en) * | 1982-12-03 | 1986-01-14 | Orest Z. Roy | Ultrasonic enhancement of cardiac contractility synchronised with ecg event or defibrillation pulse |
US4936304A (en) * | 1985-10-07 | 1990-06-26 | Thomas Jefferson University | Pacing system and method for cardiac pacing as a function of determined myocardial contractility |
US5527336A (en) * | 1986-12-09 | 1996-06-18 | Boston Scientific Corporation | Flow obstruction treatment method |
US4881549A (en) * | 1987-05-29 | 1989-11-21 | Marquette Electronics | Apparatus and method for obtaining ultrasonic backcatter measurement from tissue |
GB8717430D0 (en) * | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
CA1327838C (fr) * | 1988-06-13 | 1994-03-15 | Fred Zacouto | Dispositif implantable de protection contre les affections liees a la coagulation sanguine |
US4917115A (en) * | 1988-07-11 | 1990-04-17 | Vitatron Medical B. V. | Pacing system and method for physiological stimulation of the heart utilizing Doppler means |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5220924A (en) * | 1989-09-28 | 1993-06-22 | Frazin Leon J | Doppler-guided retrograde catheterization using transducer equipped guide wire |
US5168064A (en) * | 1990-04-20 | 1992-12-01 | The Regents Of The University Of California | Endo-1,4-β-glucanase gene and its use in plants |
EP0474957A3 (en) * | 1990-09-11 | 1992-06-24 | Bozidar Ferek-Petric | Ultrasonic doppler synchronized cardiac electrotherapy device |
US5156154A (en) * | 1991-03-08 | 1992-10-20 | Telectronics Pacing Systems, Inc. | Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques |
US5188106A (en) * | 1991-03-08 | 1993-02-23 | Telectronics Pacing Systems, Inc. | Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound |
US5139020A (en) * | 1991-03-08 | 1992-08-18 | Telectronics Pacing Systems, Inc. | Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniques |
US5183040A (en) * | 1991-03-08 | 1993-02-02 | Telectronics Pacing Systems, Inc. | Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control system |
US5156157A (en) * | 1991-03-08 | 1992-10-20 | Telectronics Pacing Systems, Inc. | Catheter-mounted doppler ultrasound transducer and signal processor |
JPH05233318A (ja) * | 1992-02-18 | 1993-09-10 | Nec Corp | マイクロプロセッサ |
US5197467A (en) * | 1992-06-22 | 1993-03-30 | Telectronics Pacing Systems, Inc. | Multiple parameter rate-responsive cardiac stimulation apparatus |
US5830848A (en) * | 1992-10-09 | 1998-11-03 | The Regents Of The University Of California | Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy |
US5508045A (en) * | 1992-10-09 | 1996-04-16 | The Regents Of The University Of California | Method and agents for control and management of labor during pregnancy |
US5344846A (en) * | 1992-12-30 | 1994-09-06 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells |
US5738096A (en) * | 1993-07-20 | 1998-04-14 | Biosense, Inc. | Cardiac electromechanics |
US5609612A (en) * | 1993-10-05 | 1997-03-11 | Sorin Biomedica Cardio S.P.A. | Device for determining myocardial function and corresponding procedure and method |
US5865738A (en) * | 1993-12-10 | 1999-02-02 | Regents Of The University Of California | Tissue viability monitor |
US5686649A (en) | 1994-03-22 | 1997-11-11 | The Rockefeller University | Suppression of plant gene expression using processing-defective RNA constructs |
US5546949A (en) * | 1994-04-26 | 1996-08-20 | Frazin; Leon | Method and apparatus of logicalizing and determining orientation of an insertion end of a probe within a biotic structure |
US5722419A (en) * | 1994-11-30 | 1998-03-03 | Semmlow; John L. | System for determining the viability of tissue |
US5544656A (en) * | 1994-12-02 | 1996-08-13 | The Regents Of The University Of California | Method and apparatus for myocardial wall measurement |
SK109997A3 (en) | 1995-02-13 | 1998-04-08 | Ciba Geigy Ag | Eukaryotic initiation factor 5a (eif-5a) mutants |
US6020139A (en) * | 1995-04-25 | 2000-02-01 | Oridigm Corporation | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
US5849587A (en) | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
US5727552A (en) * | 1996-01-11 | 1998-03-17 | Medtronic, Inc. | Catheter and electrical lead location system |
US5948771A (en) * | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
US6214572B1 (en) * | 1996-08-09 | 2001-04-10 | The General Hospital Corporation | Programmed cell death and ICH-3 |
US6024703A (en) * | 1997-05-07 | 2000-02-15 | Eclipse Surgical Technologies, Inc. | Ultrasound device for axial ranging |
US6124091A (en) * | 1997-05-30 | 2000-09-26 | Research Corporation Technologies, Inc. | Cell growth-controlling oligonucleotides |
US5749831A (en) * | 1997-06-23 | 1998-05-12 | Baker; Donald A. | Fetal cardiac monitoring utilizing umbilical blood flow parameters and heartbeat information |
EP1002079A2 (de) | 1997-06-30 | 2000-05-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Zellwachstumshemmer |
US5792199A (en) * | 1997-07-24 | 1998-08-11 | Pacesetter, Inc. | Pacemaker having rate responsive transducer and method for operating same |
US6490474B1 (en) * | 1997-08-01 | 2002-12-03 | Cardiac Pathways Corporation | System and method for electrode localization using ultrasound |
SE9702876D0 (sv) * | 1997-08-06 | 1997-08-06 | Pacesetter Ab | A cardiac monitoring device and rate responsive pacemaker system |
US5991660A (en) * | 1997-09-18 | 1999-11-23 | The Regents Of The University Of Michigan | Cardiac pacing methods |
US5836985A (en) * | 1997-09-18 | 1998-11-17 | The Regents Of The University Of Michigan | Method for treating abnormal arial or ventricular activity |
US6277077B1 (en) * | 1998-11-16 | 2001-08-21 | Cardiac Pathways Corporation | Catheter including ultrasound transducer with emissions attenuation |
US6398736B1 (en) * | 1999-03-31 | 2002-06-04 | Mayo Foundation For Medical Education And Research | Parametric imaging ultrasound catheter |
US6298269B1 (en) * | 1999-04-19 | 2001-10-02 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with ultrasound for autocapture or other applications |
US6538182B1 (en) | 1999-07-06 | 2003-03-25 | Senesco, Inc. | DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
JP2003510250A (ja) | 1999-08-06 | 2003-03-18 | ファルマシア・アンド・アップジョン・カンパニー | スタフィロコッカス・アウレウス延長因子pの結晶化および構造決定 |
US6443894B1 (en) * | 1999-09-29 | 2002-09-03 | Acuson Corporation | Medical diagnostic ultrasound system and method for mapping surface data for three dimensional imaging |
US6491639B1 (en) * | 1999-11-10 | 2002-12-10 | Pacesetter, Inc. | Extravascular hemodynamic sensor |
US6450977B1 (en) * | 2000-04-10 | 2002-09-17 | Cervilenz | Devices and methods for cervix measurement |
US7968523B2 (en) * | 2001-07-23 | 2011-06-28 | Senesco Technologies, Inc. | Method for inducing apoptosis using apoptosis-specific EIF5-A |
US7166467B2 (en) * | 2001-07-23 | 2007-01-23 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
US7217517B2 (en) * | 2001-07-23 | 2007-05-15 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, and methods for modulating apoptosis |
US7381708B2 (en) * | 2001-07-23 | 2008-06-03 | Sensco Technologies, Inc. | Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye |
-
2002
- 2002-05-07 US US10/141,647 patent/US7166467B2/en not_active Expired - Fee Related
- 2002-07-23 AT AT02759167T patent/ATE489478T1/de not_active IP Right Cessation
- 2002-07-23 IL IL15996602A patent/IL159966A0/xx unknown
- 2002-07-23 KR KR1020047000877A patent/KR100944938B1/ko not_active IP Right Cessation
- 2002-07-23 EP EP02759167A patent/EP1546375B1/de not_active Expired - Lifetime
- 2002-07-23 JP JP2003515637A patent/JP2005519583A/ja not_active Withdrawn
- 2002-07-23 DE DE60238449T patent/DE60238449D1/de not_active Expired - Lifetime
- 2002-07-23 CA CA2857312A patent/CA2857312A1/en not_active Abandoned
- 2002-07-23 CN CNB02818632XA patent/CN100352923C/zh not_active Expired - Fee Related
- 2002-07-23 NZ NZ531225A patent/NZ531225A/en not_active IP Right Cessation
- 2002-07-23 AU AU2002324519A patent/AU2002324519B2/en not_active Ceased
- 2002-07-23 CA CA2454822A patent/CA2454822C/en not_active Expired - Fee Related
- 2002-07-23 WO PCT/US2002/023254 patent/WO2003010286A2/en active Search and Examination
-
2006
- 2006-11-13 US US11/595,990 patent/US7872112B2/en not_active Expired - Fee Related
-
2011
- 2011-01-14 US US13/007,137 patent/US20120064625A1/en not_active Abandoned
- 2011-01-21 JP JP2011011061A patent/JP2011103892A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20070059831A1 (en) | 2007-03-15 |
KR20040014670A (ko) | 2004-02-14 |
CN100352923C (zh) | 2007-12-05 |
WO2003010286A3 (en) | 2005-05-06 |
US20030064952A1 (en) | 2003-04-03 |
EP1546375B1 (de) | 2010-11-24 |
JP2005519583A (ja) | 2005-07-07 |
IL159966A0 (en) | 2004-06-20 |
WO2003010286A9 (en) | 2003-12-31 |
AU2002324519A2 (en) | 2003-02-17 |
CA2454822A1 (en) | 2003-02-06 |
EP1546375A2 (de) | 2005-06-29 |
NZ531225A (en) | 2008-04-30 |
AU2002324519B2 (en) | 2008-05-15 |
JP2011103892A (ja) | 2011-06-02 |
WO2003010286A2 (en) | 2003-02-06 |
DE60238449D1 (de) | 2011-01-05 |
US20120064625A1 (en) | 2012-03-15 |
EP1546375A4 (de) | 2006-11-08 |
CA2857312A1 (en) | 2003-02-06 |
KR100944938B1 (ko) | 2010-03-02 |
CN1636064A (zh) | 2005-07-06 |
US7872112B2 (en) | 2011-01-18 |
CA2454822C (en) | 2014-09-23 |
US7166467B2 (en) | 2007-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE489478T1 (de) | Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation | |
DE60319369D1 (de) | Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis | |
ATE544473T1 (de) | Chimäre moleküle zur modulation der genexpression | |
DE69723074D1 (de) | Mch4 und mch5, apoptotische proteasen, dafür kodierende nukleinsäure und verfahren zur verwendung | |
ATE353339T1 (de) | Verfahren und zusammensetzung zur hemmung des neoplastischen zellwachstums | |
DE69840966D1 (de) | Homolog NL6 des Tie Rezeptor Tyrosinekinase Liganden | |
DE69434614D1 (de) | Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung | |
DE69533564D1 (de) | Effektor-Proteine für Rapamycin | |
IL130036A0 (en) | Survivin a protein that inhibits cellular apoptosis and its modulation | |
DE69835143D1 (de) | Selektion von proteinen mittels rns-protein fusionen | |
IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
DE69633563D1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
DE50012831D1 (de) | Verfahren zur verbindung von molekularen substanzen | |
DK1675956T3 (da) | Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression | |
ATE408029T1 (de) | Verfahren zur herstellung und identifizierung löslicher proteindomänen | |
DK1255829T3 (da) | Inhibitor af hepatocytvækstfaktoraktivator til anvendelse i modulation af angiogenese og kardiovaskularisering | |
DE69827268D1 (de) | Verfahren und zusammensetzungen zur raschen aufreinigung von proteasomen und verfahren zur verwendung entsprechender komponenten | |
ATE402948T1 (de) | Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält | |
DK1078072T3 (da) | Nye peptidfragmenter til oprensning af proteiner | |
WO2003004678A3 (en) | Novel receptors | |
ATE435914T1 (de) | Induktion der blütenbildung | |
SE0002364D0 (sv) | Growth Factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |